Understanding Hepatitis B: Current Treatment Options and Vaccination Importance

Hepatitis B is a viral infection that causes liver inflammation and damage ⁶. For individuals managing this condition, understanding available medical guidance and therapies is important for protecting long-term liver health [S3, S9]. Standard medical care relies on long-term daily medication, while newer developments aim to provide sustained viral control [S2, S3].

Navigating decisions around screening, care, and treatment requires an understanding of how the virus behaves in the body [S3, S5]. Exploring how healthcare providers diagnose, manage, and prevent hepatitis B can help you make informed choices alongside a medical professional [S3, S5].

Understanding Acute and Chronic Hepatitis B

Hepatitis B is caused by the hepatitis B virus, which spreads through contact with infected blood, semen, or other body fluids [S6, S7]. The virus can cause either an acute or chronic infection ⁶.

Acute Infection

An acute hepatitis B infection is a short-term illness occurring within the first six months after exposure to the virus ³. Many adults and children over age five experience symptoms, while younger children often do not [S6, S7]. When symptoms occur, usually two to five months after exposure, they may include dark yellow urine, fatigue, fever, joint pain, abdominal pain, nausea, vomiting, and jaundice ⁷. Most healthy adults and children older than five years recover from acute infection without developing long-term complications ⁶.

Chronic Infection

If the virus does not clear, the infection becomes chronic ⁶. Chronic hepatitis B is a long-lasting condition that can lead to serious health issues over time [S6, S9]. The chance of developing a chronic infection is higher if exposure happens at a young age or in people with weakened immune systems ⁶:

• Infants younger than age 1 year: Chronic infection develops in about 3 – 90% of infants ⁶.
• Children between ages 1 and 5 years: Chronic infection develops in 25% to 50% of children ⁶.
• Adults: Chronic infection develops in about 5% of adults ⁶.

Without regular medical monitoring, chronic hepatitis B can lead to severe liver damage, cirrhosis, and liver cancer [S6, S9].

Screening and Diagnosing Hepatitis B

Because chronic hepatitis B may not cause early symptoms, screening helps detect the virus before significant liver damage occurs ⁵. Healthcare providers use blood tests, imaging, and sometimes tissue samples to evaluate the liver ⁵.

Screening Recommendations

Healthcare professionals recommend screening for individuals with higher risk factors, including ⁵:

• Pregnant individuals ⁵.
• People born in or with parents from regions where hepatitis B is common, such as sub-Saharan Africa, Asia, Eastern Europe, and the Pacific Islands [S5, S7].
• Household contacts and sexual partners of someone with hepatitis B ⁵.
• People with multiple sexual partners or a history of sexually transmitted infections ⁵.
• People who use injected street drugs ⁵.
• Men who have sex with men ⁵.
• Individuals with HIV, hepatitis C, or unexplained abnormal liver enzyme tests ⁵.
• People receiving kidney hemodialysis or immunosuppressive medications ⁵.
• People with a history of incarceration ⁵.

Diagnostic Tests

If screening indicates viral exposure, specific tests clarify the status ⁵:

• Blood Tests: Identify whether an infection is acute or chronic, assess viral load, check immunity, and measure liver enzymes like alanine aminotransferase (ALT) [S5, S9].
• Transient Elastography: A specialized ultrasound technique used to assess the degree of liver damage ⁵.
• Liver Biopsy: A procedure where a doctor uses a thin needle to remove a small sample of liver tissue for lab examination ⁵.

Standard Hepatitis B Treatment and Management

Not everyone with chronic hepatitis B requires immediate prescription medication [S3, S9]. Treatment decisions depend on blood test results, age, and evidence of liver damage or risk of cirrhosis ⁹.

Acute Care

There is currently no specific medication available to treat acute hepatitis B ³. For mild symptoms, healthcare providers recommend rest, adequate nutrition, and fluids ³. Severe cases may require hospitalization ³.

Antiviral Therapy for Chronic Infection

For chronic hepatitis B, standard treatment involves daily oral antiviral medications [S3, S9]. Antivirals suppress viral replication, which reduces active liver inflammation and lowers the risk of developing cirrhosis and liver cancer [S3, S9].

Because standard antiviral medications suppress the virus rather than clear it entirely, individuals often need long-term or lifelong treatment ³. Stopping treatment without medical supervision can cause viral activity to rise, potentially leading to liver damage ⁹. Patients taking medications for other conditions—such as cancer therapies, immunosuppressants, or hepatitis C drugs—should inform their doctor, as certain treatments can trigger hepatitis B reactivation ⁹.

Modern Developments in Viral Control

While traditional management relies on ongoing antiviral therapy, new therapeutic options target how the virus reproduces [S2, S3].

Novel Antisense Oligonucleotide Therapy

The U.S. Food and Drug Administration (FDA) approved Hibsago (bepirovirsen), an injectable therapy developed by GSK for adults with chronic hepatitis B who do not have cirrhosis ². It is the first FDA-approved antisense oligonucleotide for hepatitis B, designed to interfere with genetic instructions used by the virus to reproduce and produce viral proteins ².

Clinical Criteria and Application

This therapy offers select eligible patients the possibility of maintaining viral control after ending chronic treatment ². Eligibility requirements include ²:

• Absence of cirrhosis ².
• Previous treatment with antiviral therapy for at least six months with suppressed blood viral levels ².
• Hepatitis B surface antigen levels of 3,000 international units per millilitre or less, verified by an FDA-authorized diagnostic test ².

In clinical trials, patients received injections under the skin for up to 24 weeks alongside their existing antiviral medication ². Wendy Carter, acting director of the FDA’s Office of Infectious Diseases, noted that Hibsago provides a new treatment approach giving some patients the possibility of maintaining viral control after chronic treatment ends ².

The Role of Vaccination in Prevention

Vaccination is the primary method for preventing hepatitis B infection [S1, S3, S6]. The hepatitis B vaccine provides protection against initial exposure, helping prevent acute illness and chronic infection [S1, S6, S7].

Universal Immunization Considerations

Public health studies highlight the role of routine immunization in maintaining low infection rates ¹. Infectious disease researchers estimate that delaying immunizations until age two would lead to a 19% increase in chronic hepatitis B cases among children and young adults in the United States ¹. If childhood vaccination were left entirely to parental choice, chronic infections could rise by 83%, leaving more than half of children born each year susceptible to infection by early adulthood ¹.

Lifestyle Habits for Liver Health

Along with medical care, lifestyle habits help protect overall liver function ³. Recommended steps include ³:

• Eating a well-balanced diet ³.
• Exercising regularly ³.
• Limiting alcohol consumption ³.
• Consulting a doctor before taking new prescription drugs or nutritional supplements ³.
• Practicing protective measures to avoid spreading the virus, such as avoiding shared razors, toothbrushes, or nail clippers ⁷.

Frequently Asked Questions

Can chronic hepatitis B be completely eliminated with treatment?

Standard antiviral medications suppress viral replication and reduce the risk of liver damage, but they generally do not eliminate the virus completely, requiring long-term treatment [S3, S9]. Newer options like Hibsago offer select patients the potential to maintain viral control after completing treatment ².

How do healthcare providers decide when to start treatment?

Not everyone diagnosed with chronic hepatitis B needs medication right away [S3, S9]. Providers evaluate blood viral load, liver enzyme levels (ALT), patient age, and signs of liver damage to determine if treatment is appropriate ⁹.

Is vaccination recommended for preventing infection?

Yes, public health organizations emphasize vaccination as the most effective way to prevent hepatitis B infection and its long-term complications [S1, S3, S6].

Navigating Your Liver Health

Managing hepatitis B involves timely screening, regular medical monitoring, healthy lifestyle choices, and preventive measures [S3, S5, S6]. Regular checkups allow healthcare providers to monitor liver function and adjust care plans as needed [S3, S9].

If you have questions about screening, treatment options, or vaccination schedules, consult a qualified healthcare professional [S3, S5].

This article is for general information only and is not medical advice. Talk to a qualified health professional about your own situation.